Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation

Saved in:
Bibliographic Details
Published in:Current Obesity Reports
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552605958930432
collection WordPress RSS
FRELIP Feed Integration
container_title Current Obesity Reports
description
discipline_display Physical Medicine and Rehabilitation
discipline_facet Physical Medicine and Rehabilitation
format Online Article
RSS Article
genre Journal Article
id rss_article:59846
institution FRELIP
journal_source_facet Current Obesity Reports
last_indexed 2026-06-20T21:23:32.361Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
Physical Medicine and Rehabilitation
General
Physical Medicine and Rehabilitation
sub_discipline_display General
sub_discipline_facet General
subject_display Physical Medicine and Rehabilitation
General
Physical Medicine and Rehabilitation
subject_facet Physical Medicine and Rehabilitation
General
Physical Medicine and Rehabilitation
title The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
title_alt El papel de los agonistas del receptor GLP1 y las terapias de incretina multiagonista para condiciones de salud específicas relacionadas con la obesidad: evidencia y fundamento para la priorización
Rôle des agonistes du récepteur GLP1 et des thérapies à incrétines multi-agonistes pour des affections spécifiques liées à l'obésité : données probantes et justification de la priorisation
O Papel dos Agonistas do Receptor GLP1 e Terapias com Incretinas Multiagonistas para Condições Específicas de Saúde Relacionadas à Obesidade: Evidências e Racional para Priorização
title_auth The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
title_es_txt El papel de los agonistas del receptor GLP1 y las terapias de incretina multiagonista para condiciones de salud específicas relacionadas con la obesidad: evidencia y fundamento para la priorización
title_fr_txt Rôle des agonistes du récepteur GLP1 et des thérapies à incrétines multi-agonistes pour des affections spécifiques liées à l'obésité : données probantes et justification de la priorisation
title_full The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
title_fullStr The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
title_full_unstemmed The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
title_pt_txt O Papel dos Agonistas do Receptor GLP1 e Terapias com Incretinas Multiagonistas para Condições Específicas de Saúde Relacionadas à Obesidade: Evidências e Racional para Priorização
title_short The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
title_sort the role of glp1 receptor agonists and multi-agonist incretin therapies for specific obesity-related health conditions: evidence and rationale for prioritisation
topic Physical Medicine and Rehabilitation
General
Physical Medicine and Rehabilitation
url https://link.springer.com/article/10.1007/s13679-026-00707-6